Abstract
The Plasmodium ookinete is a unique invasive stage which is formed following the fertilization of gametes in mosquito midguts after ingestion of infected mammalian blood. Unlike merozoites and sporozoites, ookinetes do not differentiate and proliferate inside cells; and rather penetrate the midgut epithelium and migrate through to the basal lamina, where they transform into oocysts. Sporozoites develop inside oocysts, and because sporozoites ultimately initiate malarial infections to humans, the prior ookinete stage is correspondingly a promising target to reduce malaria transmission. Ookinetes possess a distinctive crystalloid organelle which is named for its crystalline-like array of spherical particles. Recent research indicates that crystalloids influence the formation of oocysts and subsequent sporozoites, but the molecular mechanisms of the process are not understood. Here we focused on a novel crystalloid protein in Plasmodium yoelii that contains a pleckstrin homology (PH) domain. The protein is a paralog of the previously identified CryPH, and therefore we designated it PyCryPH2. Targeted disruption of the pycryph2 gene resulted in an irregular microstructure of particles within the crystalloids. While pycryph2-deficient parasites developed into morphologically normal sporozoites, the parasites had a significantly reduced ability to invade mosquito salivary glands, as well as to infect mouse liver. These findings indicate that PyCryPH2 is involved in forming crystalloids with a well-organized internal architecture and contributes to the maturation of functional sporozoites either directly or through interaction with other crystalloid proteins.
1 Introduction
Plasmodium ookinetes form in the midgut of the Anopheles mosquito following the ingestion of parasite gametocytes during a blood meal, and pass through the midgut epithelium to differentiate into oocysts on the outer side of the midgut. The ookinete stage in the mosquito is a bottleneck in the malaria life cycle, and is therefore a major target for transmission-blocking strategies (). Within the mature ookinete to early oocyst, unique intracellular organelles called crystalloids are present, which are not observed in other stages. Electron microscopy has shown that the crystalloid forms as a cluster of characteristic spherical particles and is surrounded by hemozoin and vacuoles (). The LCCL lectin adhesive proteins (LAPs), which contain adhesive domains called LCCL (Limulus clotting factor C, Coch-5b2 and Lgl1), have been studied in detail as the major crystalloid-localized proteins (; ; ; ; , ; , ). Reverse genetics studies in Plasmodium berghei have shown that deletion of LAP1 (PbSR) or LAP3 resulted in the absence of crystalloids (; ), and parasites deficient in any of the LAP family molecules were shown to have a significant inhibition of sporogony in oocysts (; ; ; ). It has been reported that disruption of two enzymes localized to crystalloids, S-acyltransferase DHHC10 and NAD(P) transhydrogenase, also resulted in failure of both crystalloid and sporozoite formation (; ). These results suggest that proteins localized to crystalloids have an important influence on sporozoite formation (sporogony) in oocysts; however, the molecular mechanisms and specific roles remain poorly understood. Many of the proteins which have been implicated in crystalloid formation, such as the LAP and CPW-WPC protein families, are found across the apicomplexan phylum, and including Cryptosporidium and proto-apicomplexans such as Chromera and Vitrella (; ; ; ). This suggests that any role suggested for the crystalloid must consider an ancient conserved function across alveolate protozoans.
In our investigation of ookinete-specific proteins in Plasmodium yoelii, we identified a novel molecule containing a pleckstrin homology (PH) domain that localizes to crystalloids and designated it as PyCryPH (PY17X_0705200) (). Subsequently, in P. berghei ookinetes, four PH domain-containing proteins, including an orthologue of PyCryPH, were reported to localize to the crystalloids (). The PH domain, a structural module of approximately 120 amino acids, is known to bind to specific phospholipids within the plasma membrane and is implicated in the intracellular signal transduction, membrane protein localization, and various physiological processes in cells (; ). However, it has been reported that putative PH domains in apicomplexans share only weak homology with classic PH domains and possess a distinct amino acid signature, suggesting parasite-specific functions (). Nevertheless, the functions of PH-domain-containing molecules localized to crystalloids have not been analyzed.
In this study, we focused on PyCryPH2 (PY17X_0705100), previously designated as PyCryPH-p in , whose gene is adjacent to pycryph in the genome in a head-to-head orientation. PyCryPH2 possesses a PH domain and shares 20% identical amino acid residues with PyCryPH. By raising specific antibodies against PyCryPH2, we demonstrated that it also localizes to crystalloids in ookinetes. Its physiological functions during mosquito-stages were investigated by targeted gene disruption in P. yoelii. Our results revealed that PyCryPH2 is involved in the formation of characteristic spherical particle structures within the crystalloid; and its loss perturbs sporozoite maturation, resulting in a reduced ability to invade salivary glands and infection of mouse liver.
2 Materials and methods
2.1 Parasites and mosquitoes
To obtain blood stage parasites, cryopreserved P. yoelii 17XNL-infected blood was intraperitoneally injected into ICR female mice (Nippon CLEA, Tokyo, Japan) which were pretreated with 1.2 mg phenyl-hydrazine to induce reticulocyte production. Mice were kept at a room temperature of 24 °C under a 12 h light/12 h dark cycle. To enrich schizonts, infected mouse blood was collected by cardiac puncture and was layered onto 55% (v/v) Nycodenz (Sigma-Aldrich, St. Louis, MO, USA) in PBS solution and centrifuged at 450 × g for 20 min at room temperature. Parasites were collected on the interface and washed twice with ice-cold PBS containing protease inhibitors (PI, Roche Applied Science, Penzberg, Germany). For in vitro ookinete culture, infected mouse blood was collected by cardiac puncture. After passing through a CF11 (Whatman, Maidstone, UK) column to remove white blood cells, the infected erythrocytes were resuspended in ookinete culture medium (RPMI 1640 medium containing 20% heat inactivated fetal calf serum, 0.367 mM hypoxanthine, 25 mM HEPES, 24 mM NaHCO3 and 5 IU/ml heparin, pH8.4), and incubated at 24 °C for 16 h. The ookinetes were collected by density-gradient centrifugation as described above. For the production of mosquito stage parasites, Anopheles stephensi SDA500 mosquitoes were allowed to feed on anesthetized P. yoelii 17XNL-infected mice, and fully engorged female mosquitoes were selected and kept at 24 °C until dissection. At days 8, 12, 13, 14, and 16 post-feeding, midguts and salivary glands were collected by dissection to assay the numbers of oocysts and sporozoites, respectively. At day 13 post-feeding, hemolymph sporozoites were collected by infusion of 100 µl of RPMI 1640 medium (FUJIFILM Wako Pure Chemical, Osaka, Japan) through the mosquito thorax; to count the number of sporozoites and to examine their motility in vitro, as described in a following gliding motility section. Sporozoites were counted using mosquitoes obtained from cages with a mean oocyst intensity of 30 or more. For RNAseq analysis midgut sporozoites at day 13 were purified using a 17% (w/v) Accudenz solution (Accurate Chemical & Scientific Corporation, Carle Place, NY, USA) ().
2.2 Antibody production
To obtain PyCryPH2 specific antibodies, a region with lower similarity compared to PyCryPH was selected to produce recombinant protein as antigen for immunization (). A fragment encoding PyCryPH2 (amino acid [aa] positions 289 to 386) was amplified by PCR from P. yoelii 17XNL genomic DNA, using PyCryPH2‐EcoRV‐F1 (5′‐tattttcagggcgatatcGCAAATTTTAAAATAAAAGGCAT‐3′) and PyCryPH2‐BamHI‐R1 (5′‐gcggtacccgggatccCTATAAATTATCATCATCATTATC‐3′). The amplified pycryph2 DNA fragment was inserted between the EcoRV and BamHI sites of the plasmid vector, pEU-E01-GST-TEV-N1 (CellFree Sciences, Matsuyama, Japan). The recombinant PyCryPH2 was expressed fused with glutathione S-transferase (GST) tag at its N-terminus and was produced using the wheat germ cell-free protein synthesis system (CellFree Sciences). Recombinant protein was purified using a Glutathione Sepharose 4B column (GE Healthcare, Camarillo, CA, USA) and eluted with elution buffer (40 mM reduced glutathione, 50 mM Tris-HCl, 300 mM NaCl, 200 mM imidazole, 2% glycerol, pH 8.0).
To generate antibodies against PyCryPH2, a Japanese white rabbit was immunized subcutaneously with 250 μg of purified recombinant PyCryPH2 emulsified in Freund’s complete adjuvant, followed by two booster immunizations with 250 μg of purified recombinant PyCryPH2 with Freund’s incomplete adjuvant. Immunizations were performed at 3-week intervals and antisera was collected 14 days after the last immunization (Kitayama labes Co. Ltd., Ina, Japan).
2.3 Western blotting
Schizont, ookinete, and sporozoite proteins were extracted in reducing SDS-PAGE loading buffer and boiled at 97 °C for 5 min, followed by electrophoretic separation on a 12% polyacrylamide gel (ATTO, Tokyo, Japan). Proteins were transferred to a 0.2 μm polyvinylidene fluoride (PVDF) membrane (ATTO), which was incubated with Blocking One (Nacalai Tesque, Inc., Kyoto, Japan) followed by immunostaining with rabbit antiserum against PyCryPH2 (1:1,000 dilution) or PyCryPH (1:1,000 dilution, ) as the primary antibody. The membranes were then probed with HRP-conjugated goat anti-rabbit IgG antibody (1:30,000 dilution, Promega, Madison, WI, USA) and visualized with Immobilon Western Chemiluminescent HRP Substrate (Merck Millipore, Billerica, MA, USA) on a LAS 4010 luminescent image analyzer or Amarsham ImageQuant800 (Cytiva, Malboorough, MA, USA). The relative molecular masses of the proteins were estimated with reference to Precision Plus Protein Standards (Bio-Rad, Hercules, CA, USA). Rabbit anti-PyCPWWPC1 antiserum (1:1,000 dilution) was used as a stage-specific loading control for ookinetes, and rabbit anti-PbRAMA antiserum (1:1,000 dilution) for schizonts and sporozoites (; ).
2.4 Indirect immunofluorescent analysis
Smears of P. yoelii 17XNL-infected blood containing schizonts and gametocytes were fixed on glass slides with 4% paraformaldehyde. Sporozoites from salivary glands were harvested at day 14 post-feeding on 8-well slides, and smears of cultured ookinetes were prepared as described above, and both were fixed with 4% paraformaldehyde. Slides were permeabilized with 0.1% Triton X-100 (Nacalai Tesque, Inc.), followed by blocking with PBS containing 5% fetal calf serum at 37 °C for 30 min. The slides were then incubated with rabbit anti-PyCryPH2 antiserum (1:100) or rabbit anti-PyCryPH antiserum (1:100) together with stage specific marker antibodies; specifically, mouse anti-Pys25 mAb (ookinete marker, 1:1,000), mouse anti-PyMSP1 antiserum (schizont marker, 1:10,000), mouse anti-PyG377 antiserum (female gametocyte marker, 1:100), or mouse anti-PyCSP antiserum (sporozoite marker, 1:100,000). Incubations were performed at 37 °C for 1 h, followed by incubation with Alexa Fluor 488-goat anti-rabbit IgG antibody and Alexa Fluor 546-goat anti-mouse IgG antibody (Invitrogen, Thermo Fisher Scientific, Carlsbad, CA, USA) as secondary antibodies (1:500 dilution) at 37 °C for 30 min, together with 1 μg/mL 4′,6-diamidino-2-phenylindole (DAPI) as a nuclear marker (; ; ; ). After mounting in ProLong Gold antifade reagent (Invitrogen, Thermo Fisher Scientific), samples were observed using a fluorescence microscope (Axio Scope.A1, Carl Zeiss, Oberkochen, Germany).
2.5 Electron microscopy
For conventional transmission electron microscopy, P. yoelii 17XNL-infected erythrocytes containing gametocytes were fixed in 2% paraformaldehyde and 2% glutaraldehyde in HEPES-buffered saline (pH 7.05), washed in the same buffer, and post-fixed in 2% osmium tetroxide. The specimens were then dehydrated in a graded series of ethanol and embedded in Epon 812 resin (TAAB Laboratories Equipment Ltd, Aldermaston, UK). For immuno-transmission electron microscopy, P. yoelii 17XNL-infected erythrocytes containing gametocytes or transgenic parasite-infected erythrocytes were fixed in 1% paraformaldehyde and 0.2% glutaraldehyde in HEPES-buffered saline (pH 7.05) and embedded in LR White resin (Polysciences, Warrington, PA, USA). Sections were blocked for 30 min in PBS containing 5% skim milk and 0.01% Tween 20 (PBS-milk-Tween 20), incubated overnight at 4 °C in PBS-milk-Tween 20 containing either rabbit anti-PyCryPH2 antiserum (1:250 dilution) or rabbit anti-PyCryPH antiserum (1:50 dilution), and then incubated at 37 °C for 1 h in PBS-milk-Tween 20 containing goat anti-rabbit IgG conjugated with 15 nm gold particles (BBI Solutions, Crumlin, UK) diluted 1:40 in PBS-milk-Tween 20. The sections were stained with 2% uranyl acetate in 50% methanol, followed by Reynold’s lead citrate solution, and then examined by transmission electron microscope (JEM-1230; JEOL, Tokyo, Japan).
2.6 Generation of transgenic parasites
The pycryph2 and pycryph genes are situated in a head-to-head orientation, and were simultaneously replaced by double crossover homologous recombination, using a drug selectable marker which encodes a fusion protein of human dihydrofolate reductase (hDHFR) and yeast cytosine deaminase and uridyl phosphoribosyl transferase (yFCU) (). The resulting double disruptant parasite line was named Δ[CryPH/CryPH2]. Taking advantage of the head-to-head genomic arrangement, the disruption plasmid was constructed to include the 3′ flanking regions of both genes in the corresponding orientations upstream and downstream of the drug selection marker expressing cassette in the plasmid pL0048 (kindly provided by Dr. Chris J. Janse and Dr. Takeshi Annoura). The 3′ flanking region (730 bp) of pycryph and the 3′ flanking region of (802 bp) of the pycryph2 were amplified from P. yoelii 17XNL genomic DNA (gDNA) using PyCryPH-3-rev-F-HindIII (5′‐gctatgcatcaagcttTAATTTTATTCATATCA‐3′) and PyCryPH-3-rev-R-KpnI (5′‐gtggatccgagctcggtaccGAATAGGGAAAAAAAAATCTCC‐3′), PyCryPH2-3-F-EcoRV (5′‐gcgaattctgcagatatcGACCAAAAGGGAAACAAAAAA‐3′) and PyCryPH2-3-R‐ApaI (5′‐ctatagggcgaattgggcccCGAAAAATGGATATGTGCCA‐3′), respectively. The fragments were inserted into HindIII and KpnI sites or EcoRV and ApaI sites, respectively, of the plasmid pL0048, which was then digested with HindIII and ApaI before transfection. Enriched schizonts of P. yoelii 17XNL were transfected with 20 μg of digested plasmid by electroporation using Nucleofector (Lonza Japan Ltd., Tokyo, Japan) with a human T cell Nucleofector kit solution and the U‐33 program, and then parasites were selected with pyrimethamine ().
pycryph2 disrupted parasites (ΔCryPH2) were generated by replacing the drug selectable marker cassette in the Δ[CryPH/CryPH2] line with a wild type pycryph gene. This genetic restoration allowed for phenotypic analysis of pycryph2 disruption. To construct the transfection plasmid, the hDHFR::yFCU drug selectable marker cassette region in the above pL0048 plasmid was replaced by the full-length PyCryPH coding sequence along with its 5’ UTR, which was amplified from P. yoelii 17XNL gDNA using PyCryPH-F (5’-tttttttccctattcGTTTTAACTATGTATGTGCATT-3’) and PyCryPH-R (5’-tgtttcccttttggtagTTGTGTGCAAGTGTGTAT-3’). Plasmid digestion and DNA transfection to Δ[CryPH/CryPH2] parasites were performed as described above, but using a Basic Parasite Nucleofector kit-2. DNA integrated parasites at the expected locus would result in the loss of the negative selectable marker, yFCU, and were selected by treatment with 5-fluorocytosine (1.5 mg/ml; Sigma-Aldrich) in the mouse drinking water. The integration of the target DNA fragment was determined by genotyping PCR. Each transgenic parasite was cloned by limiting dilution.
Control parasites (Comp[CryPH/CryPH2]) were generated by replacing the drug selectable marker cassette in Δ[CryPH/CryPH2] parasite with both of the native pycryph and pycryph2 genes. To generate a replacement construct for pycryph/pycryph2, the hdhfr::yfcu selectable marker cassette in the pL0048 plasmid constructed described above was replaced with full length pycryph and pycryph2, including each 5’ UTR amplified from P. yoelii 17XNL gDNA using PyCryPH-F and PyCryPH2-R (5’-tgtttcccttttggtCTATAAATTATCATCATCATTATC-3’). DNA transfection to Δ[CryPH/CryPH2] parasites and cloning of control parasites (Comp[CryPH/CryPH2]) were performed as described above.
2.7 PCR genotyping
The DNA integration at the expected locus was confirmed by PCR genotyping using transgenic parasite genomic DNA as template and KOD FX polymerase (TOYOBO, Osaka, Japan) with the following conditions: 94 °C for 2 min, 30 cycles of 98 °C for 10 s, 55 °C for 30 s, 68 °C for 2 min, and 68 °C for 3 min. The endogenous and restored pycryph2 loci were detected by PCR using primers, PH2-F2 (5’-TGTAATATCTCGAAAACCGGA-3’) and PH2-3-R2 (5′‐TATAATATCGTCCTTTCCCCTT‐3′). Endogenous and restored pycryph loci were detected by PCR using primers, PH-3-F1 (5′‐GAATTTGATGCTTTTCTATGAGG‐3′) and PH-R1 (5′‐CCGATATACCAAAGCATTCAAC-3’). The integration of the hdhfr::yfcu selectable marker cassette was detected by PCR using primers yFCU-F3 (5′‐GTGCCCTCGACAGAGGTCTAG‐3′) and PH2-3-R2. The PCR products were electrophoretically separated on 1.5% agarose gels.
2.8 Sporozoite infectivity to mice
P. yoelii 17XNL wild type or ΔCryPH2 sporozoites were collected from infected mosquito hemocoel at Day 13 post-feeding by infusion of 100 µl of RPMI 1640 medium. Five thousand sporozoites were intravenously inoculated into 5-week-old female BALB/c mice (n=6). Parasitemias of each mouse were assayed by microscopic examination of Giemsa stained thin-blood smears.
2.9 Sporozoite gliding motility assay
P. yoelii 17XNL wild type, ΔCryPH2, and Comp[CryPH/CryPH2] sporozoites were collected from mosquito hemolymph at days 13 post-feeding. For gliding assays, sporozoites were suspended in RPMI 1640 containing 60% FCS and were mixed with two volumes of Matrigel (Corning Inc., Corning, NY, USA), resulting in a final FCS concentration of 20%. The mixture was placed in glass-bottom dishes and incubated at 37 °C for 5 min. Sporozoite migration was recorded using an Axio Observer Z1 (Carl Zeiss) microscope every 2.6 seconds for up to 150 frames (z-stack slices were imaged at an interval of 3 µm for 8 slices). Experiments were repeated five times with at least 80 sporozoites per parasite line. Sporozoites were classified according to circulating, meandering, or non-motile gliding patterns (), and the numbers within each category were counted using Fiji software ().
2.10 RNA isolation, RNA-seq library preparation, and sequencing
Total RNA was extracted from oocyst-derived and hemolymph sporozoites at day 13 post-feeding on mice infected with ΔCryPH2 or Comp[CryPH/CryPH2] parasite lines. Oocyst-derived sporozoites were isolated from infected mosquito midguts and were purified by density gradient centrifugation using a 17% Accudenz solution (Accurate Chemical & Scientific Corporation). Hemolymph sporozoites were collected by perfusing RPMI 1640 medium through the mosquito thorax. Total RNA from the purified sporozoites was isolated using TRIzol reagent (Invitrogen, Thermo Fisher Scientific) according to the manufacturer’s instructions. RNA-seq libraries were prepared from the total RNA using an NEBNext Ultra II Directional RNA Library Prep Kit for Illumina (New England Biolab, Ipswich, MA, USA) and 150-bp paired-end reads with approximately 20 million reads per sample were sequenced on an Illumina NovaSeq platform. For oocyst-derived sporozoites, three independent biological replicates were performed for each parasite line. Raw sequencing data have been deposited in the DDBJ Sequence Read Archive (DRA) under accession number PRJDB35932.
2.11 Analysis of RNA-seq data
The obtained sequence data were mapped to the P. yoelii 17XNL reference genome from PlasmoDB-62 using HISAT2 (version 2.2.1), with the maximum intron length parameter set to 2000. To accurately quantify gene expression, a cDNA-only GFF file was generated from the P. yoelii 17XNL GTF file from PlasmoDB-62. Read counts for each gene were subsequently quantified from the mapped data using featureCounts (version 2.0.1) from the Subread package. Differential gene expression analysis of oocyst-derived sporozoite RNA-seq data was performed using the EdgeR R package (version 3.40.2). A generalized linear model (GLM) framework with a negative binomial distribution was employed to account for biological replicates, and the resulting p-values were adjusted for multiple testing using the Benjamini-Hochberg method to control for the false discovery rate (FDR). Genes were considered to be differentially expressed (DEGs), if their adjusted p-values (FDR) were less than 0.05. Unless otherwise specified, all program parameters were set to their default values. Gene Ontology (GO) enrichment analysis was conducted on DEGs from oocyst-derived sporozoites of ΔCryPH2 using the clusterProfiler R package (version 4.8.1). Separately, gene sets that were up-regulated (with a log2 fold change greater than 0.5) and down-regulated (with a log2 fold change less than -0.5) in ΔCryPH2 were analyzed. A custom GO-term database, created from the P. yoelii 17XNL GO annotation file from PlasmoDB-62, was utilized. GO terms with an FDR less than 0.05 were considered significantly enriched using the Benjamini-Hochberg method.
To identify common or unique gene expression patterns, previously reported RNA-seq data of P. yoelii 17XNL oocyst-derived sporozoites (n=3) and salivary glands-derived sporozoites (n=3) from were re-analyzed using the pipeline described above to identify DEGs. For this comparative analysis, genes with a log2 fold change greater than 1 were defined as up-regulated in oocyst-derived sporozoites, while those with a log2 fold change less than -1 were defined as up-regulated in salivary glands-derived sporozoites (implying up-regulation in salivary glands-derived sporozoites relative to oocyst-derived sporozoites). Venn diagram analysis was performed using the VennDiagram package in R (version 1.7.3) to compare the up-regulated genes in oocyst-derived sporozoites of ΔCryPH2 with the DEGs recalculated from the previously reported data.
Principal component analysis (PCA) was performed using Rstats on the Transcripts Per Million (TPM) normalized read counts. TPM values were calculated for all samples to ensure comparability across different sequencing depths. The dataset for PCA included oocyst-derived sporozoites of ΔCryPH2 and Comp[CryPH/CryPH2] (n=3 for each), hemolymph sporozoites of Comp[CryPH/CryPH2] (n=1), and the re-analyzed RNA-seq data from . The first two principal components (PC1 and PC2) were visualized using plotPCA to illustrate the overall similarities and differences among the samples.
2.12 Statistical analysis
All statistical analyses were performed using Prism 9 software (GraphPad Software, Boston, MA, USA). Non-parametric Kruskal–Wallis tests followed by Dunn’s multiple comparison post-test were used to compare three groups (PyWT, ΔCryPH2, and Comp[CryPH/CryPH2]). Mann Whitney test was applied for comparison of parasitemias between parasite lines. Statistical significance was set at P < 0.05. Two asterisks (**) indicate P values less than 0.01.
3 Results
3.1 CryPH2 is localized to the crystalloid of ookinetes
To determine PyCryPH2 localization, specific rabbit antibodies were raised against recombinant protein corresponding to the C-terminus adjacent to the PH domain of PyCryPH2 (289 aa to 386 aa), a region which has limited similarity to PyCryPH. The recombinant protein was fused at its N-terminus to glutathione S-transferase and was produced using the wheat germ protein expression system (Figure 1A). The specificity of the antisera collected from an immunized rabbit was determined by western blotting using lysates from schizont, ookinete, or sporozoite stages of Plasmodium yoelii 17XNL. Ookinetes were prepared by in vitro culture of parasite infected erythrocytes and confirmed by antibodies against the ookinete specific protein, CPWWPC-1. Western blot assays detected two proteins in ookinete lysates at approximately 44 kDa and 37 kDa (Figure 1B), which might correspond to full-length and processed forms of PyCryPH2. PyCryPH2 is localized specifically to crystalloids in ookinetes, as determined by indirect immunofluorescent assay using the specific antibodies (Figure 1C). Immunoelectron microscopic analysis further confirmed that PyCryPH2 is exclusively localized to crystalloid particles shown as a honeycomb structure (Figure 1D, Supplementary Figure 1), similar to PyCryPH ().
Figure 1
3.2 Generation of cryph2 gene disrupted parasites
To investigate the role of PyCryPH2 in mosquito stages, we generated pycryph2 gene disrupted parasites (ΔCryPH2). Initially, we attempted to obtain ΔCryPH2 transgenic parasites by homologous recombination to replace the endogenous pycryph2 locus in the P. yoelii 17XNL genome with an hDHFR and yFCU expression cassette as a selectable marker. We also planned to generate pycryph and pycryph2 double disrupted parasites (Δ[CryPH/CryPH2]) by homologous recombination as above, since these genes are located adjacent in the genome (Figure 2A). Several attempts did not succeed to isolate ΔCryPH2 parasites, while Δ[CryPH/CryPH2] transgenic parasites were generated. Therefore, we next attempted to complement Δ[CryPH/CryPH2] transgenic parasites with PyCryPH, by replacement with an hDHFR::yFCU cassette, to obtain pycryph2 disrupted parasites (ΔCryPH2). In addition, by simultaneously complementing Δ[CryPH/CryPH2] with a PyCryPH and PyCryPH2 expressing cassette, we generated control parasites (Comp[CryPH/CryPH2]) equivalent to wild type.
Figure 2
![Panel A illustrates genetic constructs and recombination strategies for manipulating cryph and cryph2 loci in Plasmodium yoelii, to generate ∆[CryPH/CryPH2], ∆CryPH2, and comp[CryPH/CryPH2]. Panel B shows PCR validation gel images with bands to determine the genotype of transgenic parasites. Panel C presents western blot images indicating expression of PyCryPH2 and PyCryPH proteins in various lines, with CPWWPC1 as a loading control. Panels D and E display fluorescence microscopy images showing localization of PyCryPH2 and PyCryPH (green), Pys25 (red), and merged images in ookinetes from different genotypes, with the DIC images.](https://www.frontiersin.org/files/Articles/1777159/xml-images/fcimb-16-1777159-g002.webp)
Generation of pycryph2-disrupted parasites and control parasites. (A) Schematic representation of the generation of pycryph/pycryph2 (upper) and pycryph2 (lower left) targeted gene disruption, together with control parasites which were restored for both pycryph and pycryph2 (lower right). Pycryph/pycryph2 double knockout parasites (Δ[CryPH/CryPH2]) were generated by replacing the pycryph and pycryph2 loci with an expression cassette of hDHFR (human dihydrofolate reductase: positive selectable marker) and yFCU (yeast cytosine deaminase and uridyl phosphoribosyl transferase: negative selectable marker) as a fusion protein (hDHFR::yFCU) by double-crossover homologous recombination. Δ[CryPH/CryPH2] transgenic parasites were selected by positive selection with pyrimethamine. Pycryph2-disrupted parasites (ΔCryPH2) and control parasites (Comp[CryPH/CryPH2]) were generated by replacing the hDHFR::yFCU expression cassette in Δ[CryPH/CryPH2] parasites with pycryph gene or both pycryph and pycryph2 genes by double-crossover homologous recombination, respectively. Both transgenic parasites were selected by negative selection with 5-fluorocytosine treatment. Locations of primers used for genotyping PCR analyses are shown as arrows. (B) Genotyping PCR to confirm DNA integration in the expected region in the transgenic parasite genome. PCRs were performed using the primers as shown in (A) to detect pycryph, pycryph2, or hdhfr::yfcu, from genomic DNA extracted from each transgenic parasite line. DNA amplification using a primer set of PH-3-F1 and PH-R1 (1055 bp), or PH2-F2 and PH2-3-R2 (1552 bp) demonstrated that pycryph or pycryph2 loci remained, respectively. In contrast, DNA amplification using a primer set of yFCU-F3 and PH2-3-R2 (1554 bp) demonstrated that the locus for the two genes was replaced by a hdhfr::yfcu expressing cassette. Panels of electrophoresis show the result of PCR genotyping using parasite genomic DNA indicated at the top. We confirmed that only the pycryph2 locus was deleted in ΔCryPH2 parasites and that both genes were restored in control (Comp[CryPH/CryPH2]) parasites. (C) Detection of PyCryPH and PyCryPH2 expression in wild type (WT) and transgenic parasites. Protein lysates of cultured ookinetes (1 × 105) of each parasite line indicated above were separated by SDS-PAGE under a reducing condition. PyCryPH2 (left panels) or PyCryPH (right panels) expression was detected using specific antibodies. As shown in Figure 1B, two bands, corresponding to the full-length and processed forms of PyCryPH2 were detected in ookinete lysates of wild type and control (Comp[CryPH/CryPH2]). Using anti-PyCryPH antiserum, two bands appeared, corresponding to full-length at approximately the calculated size (33.7 kDa) and a processed form as reported (
Gene disruption and complementation were confirmed by genotyping PCR (Figure 2B). Western blotting using specific antibodies against PyCryPH or PyCryPH2 showed that neither PyCryPH nor PyCryPH2 were detected in Δ[CryPH/CryPH2] ookinete lysates, while PyCryPH was restored in ΔCryPH2 ookinetes. Following replacement of both genes, PyCryPH and PyCryPH2 proteins were detected in Comp[CryPH/CryPH2] ookinetes similar to wild type (WT) (Figure 2C). Immunofluorescent analyses revealed that only PyCryPH2 was absent in crystalloids of ΔCryPH2 ookinetes, while both were undetectable in Δ[CryPH/CryPH2] ookinetes (Figures 2D, E). From these results, we concluded that pycryph2 gene disruption parasites were successfully generated from Δ[CryPH/CryPH2] transgenic parasites, with suitable control parasites expressing both PyCryPH and PyCryPH2 similar to wild type.
3.3 Characterization of crystalloid formation in cryph2 disrupted parasites
Ookinete crystalloids contain numerous internal particles which are often observed as a crystalline-like array. Morphological analyses of mature ookinetes by electron microscopy revealed that crystalloids, surrounded by hemozoin crystals, developed in Δ[CryPH/CryPH2] and ΔCryPH2 parasites as well as in the control (Figure 3A). Unlike for the LAP null mutant (
Figure 3
![Panel A presents six immunoelectron microscopy images of cellular cross-sections, labeled according to experimental conditions Δ[CryPH/CryPH2], ΔCryPH2, and Comp[CryPH/CryPH2] across the top, and PyCryPH2 or PyCryPH on the left demonstrating antibodies used. Panel B shows four transmission electron microscopy images comparing WT and ΔCryPH2 samples, illustrating differences in cellular ultrastructure at varied magnifications.](https://www.frontiersin.org/files/Articles/1777159/xml-images/fcimb-16-1777159-g003.webp)
PyCryPH2 is involved in microstructure formation of the crystalloid in ookinetes. (A) Immuno-EM was performed to investigate crystalloid formation and PyCryPH2 and PyCryPH localization in ookinetes of transgenic parasites. All images show crystalloids in the ookinete of transgenic parasites. In the ookinete cytosol, crystalloids, defined as honey-comb-like structures surrounded by hemozoin crystals, were detected in all examined transgenic parasite lines. Gold particles showing the localization of PyCryPH2 (upper panels) or PyCryPH (lower panels) demonstrate that PyCryPH2 was eliminated while PyCryPH was restored in crystalloids of ΔCryPH2 ookinetes. In control (Comp[CryPH/CryPH2]) ookinetes, it was confirmed that both PyCryPH and PyCryPH2 were restored in crystalloids, as in wild type. Scale bar, 500 nm. (B) Conventional EM images to investigate the detailed morphology of the particles within the crystalloids. Subunit-like particles in the crystalloid are observed in wild type and ΔCryPH2 ookinetes. In wild type (left), the crystalloid subunit particles have a characteristic spherical shape, whereas in ΔCryPH2 ookinete (right), the particles are somewhat club-shaped. The images in the center correspond to magnified views of wild type (upper) and ΔCryPH2 (bottom). The scale bar indicates 500 nm.
3.4 cryph2 disrupted parasites produce sporozoites but fail to invade salivary glands
Next, we investigated the effects of pycryph2-disruption on sporozoite formation and their capacity for invasion. The numbers of midgut oocysts at day 8 post-feeding of ΔCryPH2 infected mice (mean: 68 ± 7) were comparable to those of wild type (mean: 72 ± 6) and control parasites (mean: 75 ± 7) (Figure 4A). To determine the efficiency of sporozoite formation, egress, and invasion of salivary glands, sporozoites numbers collected from midguts (12 days), hemolymph (13 days), or salivary glands (14 days) were compared with wild type, control (Comp[CryPH/CryPH2]), and ΔCryPH2 parasites. Sporozoite numbers of ΔCryPH2 collected from midguts and hemolymph were not significantly different from those of wild type and control parasites; however, sporozoite numbers of ΔCryPH2 in salivary glands were reduced by approximately six-fold compared to wild type or control parasites (Figure 4B). These results suggest that disruption of pycryph2, which leads to the disordered formation of the crystalloid microstructure, impairs the ability of sporozoites to invade salivary glands, despite their morphologically normal formation and efficient release into the hemocoel. The double disrupted parasites, Δ[CryPH/CryPH2], exhibited a phenotype consistent with that of the pycryph2 single disrupted parasites; and showed normal oocyst and sporozoite formation, but had a significantly reduced ability to invade salivary glands (Supplementary Figure 2). These findings reinforce the conclusion that the observed defect is specifically attributable to pycryph2 disruption; particularly considering that PyCryPH has been shown to be dispensable throughout the life cycle (
Figure 4

pycryph2-disruption impaired the ability of sporozoites to invade salivary glands. (A) Numbers of mosquito midgut oocysts were counted at day 8 post-feeding from 8 independent experiments. (B) The numbers of sporozoites collected from midguts (left), hemolymph (middle), and salivary glands (right) at days 12, 13 and 14 post-feeding (n=5, 6, 8 for each), respectively, were compared among wild type, ΔCryPH2, and control (Comp[CryPH/CryPH2]) parasites. Midgut oocyst numbers were not significantly different among these parasite lines. Sporozoite formation and their release into hemocoel were similar among all lines, whereas sporozoites collected from salivary glands were significantly reduced in the ΔCryPH2 line; analyzed by the Kruskal-Wallis test with a Dunn’s post hoc test (**P < 0.01). (C) Sporozoite infectivity for mice. Hemolymph sporozoites were harvested from WT- or ΔCryPH2-infected mosquitoes at day 13 post-feeding. Five-thousand sporozoites were inoculated intravenously into BALB/c mice (n=5). Average parasitemias were determined daily by Giemsa-stained blood smears, and are plotted with standard deviations as error bars. Parasitemias of each day in ΔCryPH2 sporozoite inoculated mice were significantly lower than those of the control (Mann Whitney test, **P < 0.01). (D) Sporozoite motility was compared among wild type (WT) and transgenic parasite lines. The gliding motility of sporozoites collected from hemolymph at day 13 post-feeding was examined in vitro. Sporozoites were embedded in Matrigel and their movements were captured for 6 min by time-lapse imaging with an inverted microscope. Gliding patterns were classified into circulating (green), meandering (yellow), and non-motile (white), according to
To examine whether the low number of salivary gland-residing ΔCryPH2 sporozoites was due to delayed maturation, sporozoites were collected from midguts and salivary glands longitudinally on days 12, 14, and 16 post-feeding. In all parasite lines, wild type, ΔCryPH2, and Δ[CryPH/CryPH2], midgut sporozoite numbers decreased in a time-dependent manner, indicating that sporozoite egress occurs similarly across these lines (Supplementary Figure 3A). As previously reported (
Furthermore, ΔCryPH2 sporozoite infectivity for mice was examined by intravenous inoculation of hemolymph sporozoites into female BALB/c mice. Their parasitemias, compared to those of mice inoculated with control sporozoites, are shown in Figure 4C, demonstrating that pycryph2 disruption also decreased sporozoite infectivity to mammalian livers by approximately 25-fold compared to the control.
Since ΔCryPH2 sporozoites showed decreased abilities to invade mosquito salivary glands as well as mouse livers, we further investigated sporozoite motility, required for both invasion processes and depends on the secretion of micronemal and rhoptry proteins from the sporozoite apical complex (
3.5 Transcriptome analysis reveals a functionally immature state of ΔCryPH2 sporozoites
To investigate the reduced invasion ability due to pycryph2 disruption, transcriptome analysis was performed by RNA-seq using oocyst-derived sporozoites of ΔCryPH2 and control parasites (Comp[CryPH/CryPH2]). Approximately 2 to 6 million reads from the oocyst-derived sporozoite data were mapped to the P. yoelii genome (Supplementary Table 1). The number of mapped reads exceeds that reported in a previous RNA-seq study of P. yoelii sporozoites (
Figure 5

Developmental arrest of ΔCryPH2 sporozoites revealed by transcriptomic analysis. (A) MA plot of differentially expressed genes (DEGs) in P. yoelii oocyst-derived sporozoites. The MA plot visualizes the average log Counts Per Million (CPM) (x-axis) versus the logFC (y-axis) for all genes in ΔCryPH2 versus complemented parasite oocyst-derived sporozoites. Red points represent genes identified as significantly differentially expressed (FDR < 0.05). Representative up-regulated genes (imc1c, mtip, and ron2) are highlighted in green, while representative genes with no significant change in expression (csp, trap, and maebl) are highlighted in blue. The source data is Supplementary Table 2. (B) Gene Ontology (GO) enrichment analysis of differentially expressed genes (DEGs) in ΔCryPH2 oocyst-derived sporozoites. Bubble plots display enriched GO terms (FDR < 0.05) for genes that were up-regulated (log2 fold change > 0.5) or down-regulated (log2 fold change < -0.5) in ΔCryPH2 oocyst-derived sporozoites compared to control (Comp[CryPH/CryPH2]) parasites. The x-axis represents the gene ratio, indicating the proportion of differentially expressed genes (DEGs) relative to the total number of genes in each GO term. The dot size corresponds to the number of DEGs (count), and the color gradient represents the statistical significance based on the adjusted p-value. (C) Venn diagram analysis of shared and unique DEGs. A Venn diagram illustrates the overlap between genes up-regulated in ΔCryPH2 oocyst-derived sporozoites (ooSPZ) (log2 fold change > 0.5) and DEGs from previously reported RNA-seq data (
The transcription of some known genes related to the inner membrane complex, such as myosin A-tail interacting protein (MTIP), inner membrane complex protein 1c (IMC1c)/alveolin 5 (ALV5), and rhoptry neck protein 2 (RON2) were enhanced in ΔCryPH2 sporozoites (Figure 5A, Supplementary Figure 3). Therefore, we applied gene ontology analysis, resulting in significant enrichment of inner membrane pellicle complex group molecules, including both MTIP and IMC1c, in the genes upregulated by pycryph2 disruption (Figure 5B). The inner membrane complex (IMC) is required for sporozoite elongated structure and motility and is formed at an earlier stage during sporogony; thus gene expression related to IMC is upregulated in oocyst-derived sporozoites compared to further matured sporozoites collected from salivary glands (
This analysis provides further support for the hypothesis that the ΔCryPH2 sporozoites remain in an immature state inside oocysts, which may lead to their reduced ability to invade salivary glands. Further investigations are required to elucidate the specific mechanism by which the disordered formation of crystalloid microstructure, caused by the disruption of pycryph2, impacts the sporozoite functional maturation sufficient to invade salivary glands, particularly since both PyCryPH2 and crystalloids are absent in sporozoites.
4 Discussion
The pleckstrin homology (PH) domain consists of approximately 120 amino acids and is widely found in eukaryotes, and is known to be involved in intracellular signal transduction and interactions with membranes (
The relationship between the characteristic structure of the crystalloid and its roles in ookinetes, oocysts, and sporozoite development are questions to be addressed; and at this juncture are approached by describing phenotypic changes following targeted gene disruptions. The disruption of the ookinete crystalloid structure by PbLAP1 deletion resulted in the failure of sporogony in oocysts at the next stage (
To better understand the relationship of gene expression patterns and the observed phenotype, transcriptomes were analyzed by RNA-seq to investigate any disorders occurring in developing sporozoites in oocysts caused by pycryph2 disruption. RNA-seq results showed that key transcript levels of major sporozoite molecules implicated in sporozoite motility or invasion of salivary glands, such as, CSP, TRAP, and MAEBL (
This study revealed that PyCryPH2 localizes to the crystalloid, an organelle unique to ookinetes, and is involved in the microstructure of crystalloids. Loss of PyCryPH2 influences sporozoite maturation, leading to a deficiency in the invasion of salivary glands and the infection of mammalian livers. Our findings, taken together with previous studies, indicate that crystalloid proteins such as LAP family, DHHC10, NAD(P) transhydrogenase, and PyCryPH2 are indirectly required for sporozoite formation and/or maturation, albeit to different degrees. Elucidating the molecular mechanisms that link pycryph2 disruption to aberrant crystalloid microstructure and subsequent impaired sporozoite maturation for invasion is a critical next step to reveal the comprehensive roles of crystalloids in malaria parasite transmission from mosquito vectors to mammals.
Statements
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: https://www.ddbj.nig.ac.jp/, PRJDB35932.
Ethics statement
The animal study was approved by Ethical Committee for Animal Experiments of Ehime University. The study was conducted in accordance with the local legislation and institutional requirements.
Author contributions
MaT: Data curation, Investigation, Writing – original draft, Funding acquisition. NS: Data curation, Writing – review & editing, Investigation, Methodology. MB: Investigation, Methodology, Writing – review & editing. MoT: Conceptualization, Data curation, Project administration, Writing – original draft, Writing – review & editing, Investigation. RC: Conceptualization, Writing – review & editing. TI: Conceptualization, Data curation, Funding acquisition, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing, Visualization.
Funding
The author(s) declared that financial support was received for this work and/or its publication. This work was supported in part by JSPS KAKENHI (JP24KK0149 to TI, JP24K10190 to MaT, and JP21K06991 to MaT). This work was also supported by SHIONOGI INFECTIOUS DISEASE RESEARCH PROMOTION FOUNDATION (2023F020) to TI, and by AMED under Grant Number JP25wm0325074 to TI and JP25wm0325060 to NS.
Acknowledgments
We are grateful to Dr. Chris J. Janse, Leiden University Medical Centre (LUMC), and Dr. Takeshi Annoura, Japan Institute for Health Security (JIHS-NIID), for providing plasmid pL0048. We thank Dr. Thomas Templeton for critical reading of the manuscript. This study was supported by the Division of Medical Research Support, the Advanced Research Support Center (ADRES), Ehime University. We also thank Aki Konishi and Sono Sadaoka for rearing mice and technical support.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2026.1777159/full#supplementary-material
References
1
AbrahamsenM. S.TempletonT. J.EnomotoS.AbrahanteJ. E.ZhuG.LanctoC. A.et al. (2004). Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science304, 441–445. doi: 10.1126/science.1094786. PMID:
2
BraumannF.KlugD.KehrerJ.SongG.FengJ.SpringerT. A.et al. (2023). Conformational change ofPlasmodium TRAP is essential for sporozoite migration and transmission. EMBO Rep.24, e57064. doi: 10.15252/embr.202357064. PMID:
3
CarterV.ShimizuS.AraiM.DessensJ. T. (2008). PbSR is synthesized in macrogametocytes and involved in formation of the malaria crystalloids. Mol. Microbiol.68, 1560–1569. doi: 10.1111/j.1365-2958.2008.06254.x. PMID:
4
ChaiyawongN.IshizakiT.HakimiH.AsadaM.YahataK.KanekoO. (2022). Distinct effects on the secretion of MTRAP and AMA1 in Plasmodium yoelii following deletion of acylated pleckstrin homology domain-containing protein. Parasitol. Int.86, 102479. doi: 10.1016/j.parint.2021.102479. PMID:
5
ClaudianosC.DessensJ. T.TruemanT. H.AraiM.MendozaJ.ButcherG. A.et al. (2002). A malaria scavenger receptor-like protein essential for parasite development. Mol. Microbiol.45, 1473–1484. doi: 10.1046/j.1365-2958.2002.03118.x. PMID:
6
DessensJ. T.SaeedS.TrempA. Z.CarterV. (2011). Malaria crystalloids: specialized structures for parasite transmission? Trends Parasitol.27, 106–110. doi: 10.1016/j.pt.2010.12.004. PMID:
7
EckerA.BushellE. S. C.TewariR.SindenR. E. (2008). Reverse genetics screen identifies six proteins important for malaria development in the mosquito. Mol. Microbiol.70, 209–220. doi: 10.1111/j.1365-2958.2008.06407.x. PMID:
8
GhoshA. K.Jacobs-LorenaM. (2009). Plasmodium sporozoite invasion of the mosquito salivary gland. Curr. Opin. Microbiol.12, 394–400. doi: 10.1016/j.mib.2009.06.010. PMID:
9
IshinoT.MurataE.TokunagaN.BabaM.TachibanaM.ThongkukiatkulA.et al. (2019). Rhoptry neck protein 2 expressed inPlasmodium sporozoites plays a crucial role during invasion of mosquito salivary glands. Cell. Microbiol.21, e12964. doi: 10.1111/cmi.12964. PMID:
10
IshinoT.TachibanaM.BabaM.IrikoH.TsuboiT.ToriiM. (2020). Observation of morphological changes of female osmiophilic bodies prior toPlasmodium gametocyte egress from erythrocytes. Mol. Biochem. Parasitol.236, 111261. doi: 10.1016/j.molbiopara.2020.111261. PMID:
11
JanseC. J.RamesarJ.WatersA. P. (2006). High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat. Protoc.1, 346–356. doi: 10.1038/nprot.2006.53. PMID:
12
JenwithisukR.KangwanrangsanN.TachibanaM.ThongkukiatkulA.OtsukiH.SattabongkotJ.et al. (2018). Identification of a PH domain-containing protein which is localized to crystalloid bodies ofPlasmodium ookinetes. Malar. J.17, 466. doi: 10.1186/s12936-018-2617-6. PMID:
13
KangwanrangsanN.TachibanaM.JenwithisukR.TsuboiT.RiengrojpitakS.ToriiM.et al. (2013). A member of the CPW-WPC protein family is expressed in and localized to the surface of developing ookinetes. Malar. J.12, 129. doi: 10.1186/1475-2875-12-129. PMID:
14
KennedyM.FishbaugherM. E.VaughanA. M.PatrapuvichR.BoonhokR.YimamnuaychokN.et al. (2012). A rapid and scalable density gradient purification method forPlasmodium sporozoites. Malar. J.11, 421. doi: 10.1186/1475-2875-11-421. PMID:
15
KojinB. B.AdelmanZ. N. (2019). The Sporozoite’s journey through the mosquito: A critical examination of host and parasite factors required for salivary gland invasion. Front. Ecol. Evol.7, 284. doi: 10.3389/fevo.2019.00284
16
KumarP.TripathiA.RanjanR.HalbertJ.GilbergerT.DoerigC.et al. (2014). Regulation of Plasmodium falciparum development by calcium-dependent protein kinase 7 (PfCDPK7). J. Biol. Chem.289, 20386–20395. doi: 10.1074/jbc.M114.561670. PMID:
17
LavazecC.MoreiraC. K.MairG. R.WatersA. P.JanseC. J.TempletonT. J. (2009). Analysis of mutant Plasmodium berghei parasites lacking expression of multiple PbCCp genes. Mol. Biochem. Parasitol.163, 1–7. doi: 10.1016/j.molbiopara.2008.09.002. PMID:
18
LemmonM. A. (2007). Pleckstrin homology (PH) domains and phosphoinositides. Biochem. Soc Symp.74, 81–93. doi: 10.1042/BSS2007c08
19
LinJ. W.AnnouraT.SajidM.Chevalley-MaurelS.RamesarJ.KlopO.et al. (2011). A novel ‘gene insertion/marker out’ (GIMO) method for transgene expression and gene complementation in rodent malaria parasites. PLOS ONE6, e29289. doi: 10.1371/journal.pone.0029289. PMID:
20
LindnerS. E.SwearingenK. E.ShearsM. J.WalkerM. P.VranaE. N.HartK. J.et al. (2019). Transcriptomics and proteomics reveal two waves of translational repression during the maturation of malaria parasite sporozoites. Nat. Commun.10, 4964. doi: 10.1038/s41467-019-12936-6. PMID:
21
MeisJ. F.PonnuduraiT. (1987). Ultrastructural studies on the interaction of Plasmodium falciparum ookinetes with the midgut epithelium of Anopheles stephensi mosquitoes. Parasitol. Res.73, 500–506. doi: 10.1007/BF00535323. PMID:
22
NozakiM.BabaM.TachibanaM.TokunagaN.ToriiM.IshinoT. (2020). Detection of the rhoptry neck protein complex inPlasmodium sporozoites and its contribution to sporozoite invasion of salivary glands. mSphere5, e00325-20. doi: 10.1128/mSphere.00325-20. PMID:
23
OtsukiH.YokouchiY.IyokuN.TachibanaM.TsuboiT.ToriiM. (2015). The rodent malaria lactate dehydrogenase assay provides a high throughput solution for in vivo vaccine studies. Parasitol. Int.64, 60–63. doi: 10.1016/j.parint.2015.02.001. PMID:
24
PowisG.MeuilletE. J.IndarteM.BooherG.KirkpatrickL. (2023). Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease. Biomed. Pharmacother.165, 115024. doi: 10.1016/j.biopha.2023.115024. PMID:
25
RaineJ. D.EckerA.MendozaJ.TewariR.StanwayR. R.SindenR. E. (2007). Female inheritance of malarial lap genes is essential for mosquito transmission. PLOS Pathog.3, e30. doi: 10.1371/journal.ppat.0030030. PMID:
26
RaoP. N.SantosJ. M.PainA.TempletonT. J.MairG. R. (2016). Translational repression of the cpw-wpc gene family in the malaria parasite Plasmodium. Parasitol. Int.65, 463–471. doi: 10.1016/j.parint.2016.06.007. PMID:
27
SaeedS.CarterV.TrempA. Z.DessensJ. T. (2010). Plasmodium berghei crystalloids contain multiple LCCL proteins. Mol. Biochem. Parasitol.170, 49–53. doi: 10.1016/j.molbiopara.2009.11.008. PMID:
28
SaeedS.CarterV.TrempA. Z.DessensJ. T. (2013). Translational repression controls temporal expression of the Plasmodium berghei LCCL protein complex. Mol. Biochem. Parasitol.189, 38–42. doi: 10.1016/j.molbiopara.2013.04.006. PMID:
29
SaeedS.TrempA. Z.DessensJ. T. (2015). Biogenesis of the crystalloid organelle inPlasmodium involves microtubule-dependent vesicle transport and assembly. Int. J. Parasitol.45, 537–547. doi: 10.1016/j.ijpara.2015.03.002. PMID:
30
SaeedS.TrempA. Z.DessensJ. T. (2018). ThePlasmodium LAP complex affects crystalloid biogenesis and oocyst cell division. Int. J. Parasitol.48, 1073–1078. doi: 10.1016/j.ijpara.2018.09.002. PMID:
31
SaeedS.TrempA. Z.SharmaV.LasonderE.DessensJ. T. (2020). NAD(P) transhydrogenase has vital non-mitochondrial functions in malaria parasite transmission. EMBO Rep.21, e47832. doi: 10.15252/embr.201947832. PMID:
32
SantosJ. M.DuarteN.KehrerJ.RamesarJ.AvramutM. C.KosterA. J.et al. (2016). Maternally supplied S-acyl-transferase is required for crystalloid organelle formation and transmission of the malaria parasite. Proc. Natl. Acad. Sci. U.S.A.113, 7183–7188. doi: 10.1073/pnas.1522381113. PMID:
33
SchindelinJ.Arganda-CarrerasI.FriseE.KaynigV.LongairM.PietzschT.et al. (2012). Fiji: an open-source platform for biological-image analysis. Nat. Methods9, 676–682. doi: 10.1038/nmeth.2019. PMID:
34
SindenR. E. (2017). Developing transmission-blocking strategies for malaria control. PLOS Pathog.13, e1006336. doi: 10.1371/journal.ppat.1006336. PMID:
35
SuarezC.LentiniG.RamaswamyR.MaynadierM.AquiliniE.Berry-SterkersL.et al. (2019). A lipid-binding protein mediates rhoptry discharge and invasion in Plasmodium falciparum and Toxoplasma gondii parasites. Nat. Commun.10, 4041. doi: 10.1038/s41467-019-11979-z. PMID:
36
SultanA. A.ThathyV.FrevertU.RobsonK. J. H.CrisantiA.NussenzweigV.et al. (1997). TRAP is necessary for gliding motility and infectivity ofPlasmodium sporozoites. Cell90, 511–522. doi: 10.1016/s0092-8674(00)80511-5. PMID:
37
TachibanaM.BabaM.IrikoH.ShinzawaN.ToriiM.IshinoT. (2024). Identification of a novel protein localized to the crystalloid of thePlasmodium ookinete. Parasitol. Int.101, 102892. doi: 10.1016/j.parint.2024.102892. PMID:
38
TempletonT. J.PainA. (2016). Diversity of extracellular proteins during the transition from the ‘proto-apicomplexan’ alveolates to the apicomplexan obligate parasites. Parasitology143, 1–17. doi: 10.1017/S0031182015001213. PMID:
39
TosiniF.AgnoliA.MeleR.Gomez MoralesM. A.PozioE. (2004). A new modular protein of Cryptosporidium parvum, with ricin B and LCCL domains, expressed in the sporozoite invasive stage. Mol. Biochem. Parasitol.134, 137–147. doi: 10.1016/j.molbiopara.2003.11.014. PMID:
40
TrempA. Z.SaeedS.SharmaV.LasonderE.DessensJ. T. (2020). Plasmodium berghei LAPs form an extended protein complex that facilitates crystalloid targeting and biogenesis. J. Proteomics227, 103925. doi: 10.1016/j.jprot.2020.103925. PMID:
41
TsuboiT.CaoY. M.HitsumotoT.YanagiT.KanbaraH.ToriiM. (1997). Two antigens on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei that are distinct targets of transmission-blocking immunity. Infect. Immun.65, 2260–2264. doi: 10.1128/iai.65.6.2260-2264.1997. PMID:
42
UkegbuC. V.GomesA. R.GiorgalliM.CamposM.BaileyA. J.BessonT. R. B.et al. (2023). Identification of genes required forPlasmodium gametocyte-to-sporozoite development in the mosquito vector. Cell Host Microbe31, 1539–1551. doi: 10.1016/j.chom.2023.08.010. PMID:
43
ZhangM.KanekoI.TsaoT.MitchellR.NardinE. H.IwanagaS.et al. (2016). A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein. Malar. J.15, 202. doi: 10.1186/s12936-016-1248-z. PMID:
Summary
Keywords
crystalloid, ookinete, Plasmodium, pleckstrin homology (PH) domain, sporozoite invasion
Citation
Tachibana M, Shinzawa N, Baba M, Torii M, Culleton R and Ishino T (2026) A pleckstrin homology domain protein is involved in crystalloid formation in Plasmodium ookinetes and affects the maturation of infective sporozoites. Front. Cell. Infect. Microbiol. 16:1777159. doi: 10.3389/fcimb.2026.1777159
Received
29 December 2025
Revised
16 April 2026
Accepted
17 April 2026
Published
18 May 2026
Volume
16 - 2026
Edited by
Sudhir Kumar, Iowa State University, United States
Reviewed by
Jun Miao, University of South Florida, United States
Johannes Theodorus Dessens, London School of Hygiene and Tropical Medicine, United Kingdom
Oluwatobi Sarah Otun, University of Witwatersrand, South Africa
Updates

Check for updates
Copyright
© 2026 Tachibana, Shinzawa, Baba, Torii, Culleton and Ishino.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tomoko Ishino, tishino.vip@tmd.ac.jp
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.